HUM:NYE-Humana Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 259.76

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.55M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-09 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 481.78B
ELV Elevance Health Inc

N/A

USD 90.78B
CNC Centene Corp

N/A

USD 28.20B
MOH Molina Healthcare Inc

N/A

USD 15.11B
OSCR Oscar Health Inc

N/A

USD 3.66B
NEUE NeueHealth Inc

N/A

USD 0.06B
CI Cigna Corp

N/A

N/A
CVS CVS Health Corp

N/A

N/A

ETFs Containing HUM

TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

N/A

CAD 0.01B
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

N/A

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

N/A

N/A
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

N/A

N/A
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
VETS 0.00 % 0.60 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.38% 44% F 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.38% 44% F 67% D+
Trailing 12 Months  
Capital Gain -23.45% 11% F 11% F
Dividend Return 1.30% 40% F 23% F
Total Return -22.15% 22% F 11% F
Trailing 5 Years  
Capital Gain -25.63% 17% F 15% F
Dividend Return 4.70% 25% F 10% F
Total Return -20.93% 17% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.57% 11% F 21% F
Dividend Return -1.86% 11% F 14% F
Total Return 0.70% 40% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 21.87% 78% C+ 50% F
Risk Adjusted Return -8.52% 22% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector